• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,847.57 -702.68
( -0.91%)
Global Indices
Nasdaq
47,930.49 -276.32
(-0.57%)
Dow Jones
6,837.38 -8.28
(-0.12%)
Hang Seng
56,484.90 -439.21
(-0.77%)
Nikkei 225
10,596.33 -7.15
(-0.07%)
Forex
USD-INR
92.50 0.06
(0.07%)
EUR-INR
108.05 0.09
(0.08%)
GBP-INR
124.08 0.03
(0.03%)
JPY-INR
0.58 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524500
INE729D01010
90.3656032
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KILITCH
15.06
448.73
EPS(TTM)
Face Value()
Div & Yield %
8.52
10
0
 

Sriven Multi-Tech reports standalone net loss of Rs 0.03 crore in the September 2025 quarter
Nov 26,2025
Net Loss of Sriven Multi-Tech reported to Rs 0.03 crore in the quarter ended September 2025 as against net loss of Rs 0.03 crore during the previous quarter ended September 2024. Sales rose 100.00% to Rs 0.02 crore in the quarter ended September 2025 as against Rs 0.01 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.020.01 100
OPM %-150.00-300.00 -
PBDT-0.03-0.03 0
PBT-0.03-0.03 0
NP-0.03-0.03 0